Trial intelligence / Profile preview

MPA in familial adenomatous polyposis proof-of-principle study

NL-OMON25407Not yet recruiting

Sponsor
afdeling maag darm en leverziekten LUMC
Start
Aug 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of medroxyprogesterone acetate in Colonic Adenomatous Polyposis, sponsored by afdeling maag darm en leverziekten LUMC. Primary endpoints: Change in polyp burden and Endoscopic Appearance of Polyposis index. Planned start Aug 2008; status: not yet recruiting.

02

Drugs

medroxyprogesterone acetate
03

Conditions

Colonic Adenomatous Polyposis

Beyond the preview

Go deeper on NL-OMON25407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call